The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The Frequency of Cognitive Impairment in Patients With Anxiety, Depression, and Bipolar Disorder: An Unaccounted Source of Variance in Clinical Trials
Abstract
BACKGROUND: Patients with anxiety, depression, and bipolar disorder are known to be impaired relative to healthy controls on neurocognitive tests, but the degree of impairment may be obscured if the data are analyzed in terms of group means. METHOD: Patients and controls were administered a comprehensive neurocognitive assessment that measured performance in 5 domains: memory, psychomotor speed, reaction time, attention, and cognitive flexibility. Clinic patients diagnosed per DSM-IV-TR criteria with generalized anxiety disorder (N = 63), major depressive disorder (N = 285), and bipolar I or II disorder (N = 96) were compared with 907 controls. Subjects' age range was 18 to 65 years. Patients had no comorbid psychiatric disorders and no medical, neurologic, or developmental conditions that might affect cognition (e.g., attention-deficit/hyperactivity disorder, brain injury, mild cognitive impairment, chronic pain). Data on patients and controls (collected from March 2003 through February 2007) were taken from a clinical database that also contained neurocognitive test scores. RESULTS: There were small differences between patients and controls, between different patient groups, and between treated and untreated patients when neurocognitive results in terms of group means were compared. Comparisons of results in terms of the frequency with which patients and controls fell below certain cutoff scores amplified the importance of these differences. Only 4% of controls fell below a standard score of 70 (2 standard deviations below the mean) on 2 or more cognitive domains, but 19% of anxiety patients, 21% of depressed patients, and 30% of bipolar patients fell below the standard score. CONCLUSIONS: Substantial numbers of patients with anxiety, depression, and bipolar disorder are cognitively impaired. A score that is 2 standard deviations below the mean is usually clinically important, and 2 domain scores in that range is cause for serious concern. The importance of this finding is discussed, with respect to clinical trials, in terms of establishing a homogeneous trial population and minimizing the placebo response rate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mood disorders are also associated with impairments in cognitive functioning.”
From A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder (2015) · cites this paper as Gualtieri and Morgan, 2008
In the citing paper
“Many patients suffering from MDD present some form of dysfunction in certain cognitive domains; this affects >60% of all depressed patients and significantly impacts treatment outcomes (Bora et al, 2013; Gualtieri and Morgan, 2008; Lee et al, 2012; Murrough et al, 2011; Rock et al, 2014; Trivedi and Greer, 2014).”
From A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder (2015) · cites this paper as Gualtieri and Morgan, 2008
In the citing paper
“However, a subpopulation of MDD patients (approximately 20 %) exhibited deficits of two standard deviations below the mean on two or more cognitive domains [6].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [6]
Citations
Cites
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
L’examen Clinique en Psychologie
Rubé, P. (1959) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1959.13.4.989 · Cited by 3,302
Smith's recognizable patterns of human malformation
Jones, K. L., Jones, M. C., & Campo, M. D. (1997) · Cited by 1,916
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109
Chaytor, N., & Schmitter-Edgecombe, M. (2003) · Neuropsychology Review · doi:10.1023/b:nerv.0000009483.91468.fb · Cited by 1,055
Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972
Reliability and validity of a computerized neurocognitive test battery, CNS vital signs
GUALTIERI, C., & JOHNSON, L. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2006.05.007 · Cited by 873
Self-citationIs MCI really just early dementia? A systematic review of conversion studies
Bruscoli, M., & Lovestone, S. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000092 · Cited by 550
Sustained attention deficit in bipolar disorder
Clark, L., Iversen, S. D., & Goodwin, G. M. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.4.313 · Cited by 539
Neurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519
Cited by
Depression: A cognitive perspective
LeMoult, J., & Gotlib, I. H. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.06.008 · Cited by 792
McTeague, L. M., Huemer, J., Carreon, D. M., Jiang, Y., Eickhoff, S. B., & Etkin, A. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16040400 · Cited by 635
“, domain nonspecifically) perturbed, with some variations in severity (4, 5).”
BackgroundMiskowiak, K., Johnsen, S., Sattler, S., Nielsen, S., Kunalan, K., Rungby, J., Lapperre, T., & Porsberg, C. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.03.019 · Cited by 365
Current perspectives of the roles of the central norepinephrine system in anxiety and depression
Goddard, A. W., Ball, S. G., Martinez, J., Robinson, M. J., Yang, C. R., Russell, J. M., & Shekhar, A. (2010) · Depression and Anxiety · doi:10.1002/da.20642 · Cited by 316
Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y., & Keefe, R. S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.52 · Cited by 307
Metadata
- Authors
- Gualtieri, C. T., & Morgan, D. W.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-07-15
- Volume
- 69
- Issue
- 7
- Pages
- 1122-1130
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2054509928
- Cited by
- 275
- References
- 44
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 11 · 2023: 23 · 2022: 21 · 2021: 14 · 2020: 19 · 2019: 21 · 2018: 26 · 2017: 16 · 2016: 22 · 2015: 26 · 2014: 9 · 2013: 8 · 2012: 8
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- cognitive impairment, generalized anxiety disorder, major depressive disorder, bipolar disorder, neuropsychological assessment, memory, psychomotor speed, reaction time, attention, cognitive flexibility, cut-off values, placebo response
- MeSH terms
- Adolescent, Adult, Aged, Anxiety Disorders, Bipolar Disorder, Clinical Trials as Topic, Cognition Disorders, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Severity of Illness Index, Incidence, Prevalence, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Frequency of Cognitive Impairment in Patients With Anxiety, Depression, and Bipolar Disorder: An Unaccounted Source of Variance in Clinical Trials. https://app.cochat.ai/papers/10.4088/jcp.v69n0712
- The paper
- Gualtieri, C. T., & Morgan, D. W. (2008). The Frequency of Cognitive Impairment in Patients With Anxiety, Depression, and Bipolar Disorder: An Unaccounted Source of Variance in Clinical Trials. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v69n0712
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.